Inductive Bio is an innovative biotechnology company focused on developing an AI-driven compound optimization platform that significantly enhances the drug discovery process. By leveraging advanced AI models trained on a proprietary ADMET dataset, Inductive Bio accelerates hit-to-lead and lead optimization for over 30 active drug programs in collaboration with leading biopharma partners. The company is backed by top investors and guided by experienced drug hunters, positioning itself as a preferred partner for biopharma companies seeking to advance their drug development efforts. Inductive Bio fosters a collaborative and dynamic work environment, emphasizing the importance of its team members and offering competitive compensation and benefits as it scales rapidly in the industry.